Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma

Blood

Volumn 93, Issue 9, 1999, Pages 3064-3073

  Vacca, Angelo ^b   Ribatti, Domenico ^b   Presta, Marco ^b   Minischetti, Monica ^b   Iurlaro, Monica ^b   Ria, Roberto ^b   Albini, Adriana ^b   Bussolino, Federico ^b   Dammacco, Franco ^a  

^a POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; PLASMA CELL; PRIORITY JOURNAL;

EID: 0033134764     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.3064     Document Type: Article

References (46)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27, 1995
2. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161, 1993
3. Ellis LM, Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 32A:2451, 1996
4. Noël A, Emonard H, Polette M, Birembaut Ph, Foidart JM: Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Pathol Res Pract 190:934, 1994
5. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062, 1994
6. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F: Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503, 1994
7. Perez-Atayde AR, Sallan SE, Tedrow U, Connors EA, Folkman J: Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150:815, 1997
8. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F: Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 56:45, 1996
9. Barillè S, Akhoundi C, Collette M, Mellerin M-P, Rapp M-J, Harousseau J-L, Bataille R, Amiot M: Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood 90:1649, 1997
10. Kossakowska AE, Hinek A, Edwards DR, Lim MS, Zhang C-L, Breitman DR, Prusinkiewicz C, Stabbler AL, Urbanski LS, Urbanski SJ: Proteolytic activity of human non-Hodgkin's lymphoma. Am J Pathol 152:565, 1998
11. Durie BGM, Salmon SE: Multiple myeloma, macroglobulinemia and monoclonal gammapathies, in Hoffbrand AV, Brain MC, Hirsh J (eds): Recent Advances in Hematology. New York, NY, Churchill Livingstone, 1977, p 243
12. Durie BGM: Staging and kinetics of multiple myeloma, in Wiernik PH, Canellos GP, Kyle RA, Schiffer CA (eds): Neoplastic Diseases of the Blood. New York, NY, Churchill Livingstone, 1991, p 439
13. Vacca A, Di Loreto M, Ribatti D, Di Stefano R, Gadaleta-Caldarola G, Iodice G, Caloro D, Dammacco F: Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1 and CD44. Am J Hematol 50:9, 1995
14. Elias H, Hyde DM: Stereological measurements of isotropic structures, in Elias H, Hyde DM (eds): A Guide to Practical Stereology. Basel, Switzerland, Karger, 1983, p 25
15. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to malignant plasma cells. J Exp Med 178:1023, 1993
16. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629, 1992
17. Albini A, Repetto L, Carlone S, Benelli R, Soria M, Monaco L, Gendelman R, De Filippi P, Bussolino F, Parravicini C: Characterization of Kaposi's sarcoma-derived cell cultures from an epidemic and a classic case. Int J Oncol 1:723, 1992
18. Bussolino F, Arese M, Montrucchio G, Barra L, Primo L, Benelli R, Sanavio F, Aglietta M, Ghigo D, Rola-Pleszczynski M, Bosia A, Albini A, Camussi G: Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 96:940, 1995
19. Kueng K, Silfer E, Eppenberger V: Quantification of cells cultured on 96-well plates. Anal Biochem 182:16, 1989
20. Albini A, Melchiori A, Parodi S, Kleinman H: Chemotaxis and invasiveness, in Lapière CM, Krieg T (eds): Connective Tissue Disease of the Skin. New York, NY, Marcel Dekker, 1993, p 129
21. Martinet Y, Martinet N, Vignaud J-M, Plenat F: Blood monocyte chemotaxis. J Immunol Methods 174:209, 1994
22. Ribatti D, Gualandris A, Bastaki M, Vacca A, Roncali L, Presta M: New model for the study of angiogenesis in the chick embryo chorioallantoic membrane. J Vasc Res 34:455, 1997
23. Olivo M, Bhardway R, Schulze-Osthoff K, Sorg C, Jürgen-Jacob H, Flamme I: A comparative study on the effects of tumor necrosis factor-α (TNF-α), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 234:105, 1992
24. Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F, Parolini S, Albini A, Morbidelli L, Ziche M, Corallini A, Possati L, Vacca A, Ribatti D, Presta M: Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 7:147, 1996
25. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEvan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239, 1987
26. Vacca A, Moretti S, Ribatti D, Pellegrino A, Pimpinelli N, Bianchi E, Bonifazi E, Ria R, Serio G, Dammacco F:Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer 33:1685, 1997
27. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K: Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 266:16485, 1991
28. Gualandris A, Urbinati C, Rusnati M, Ziche M, Presta M: Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: Biological activity and intercellular gate of human recombinant Mr 24,000 bFGF. J Cell Physiol 161:149, 1994
29. Tanaka E, Ase K, Okuda T, Okumura M, Nogimori K: Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol Pharm Bull 19:1141, 1996
30. Hanahan D, Folkman J: Pattern and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353, 1996
31. Folkman J: Tumor angiogenesis, in Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (eds): Cancer Medicine (ed 3), vol I. Philadelphia, PA, Lea & Febiger, 1993, p 153
32. Watanabe M, McCormick KL, Volker K, Ortaldo JR, Wiggington JM, Brunda MJ, Wiltrout RH, Fogler WE: Regulation of local host-mediated anti-tumor mechanisms by cytokines. Direct and indirect effects on leukocyte recruitment and angiogenesis. Am J Pathol 150:1869, 1997
33. Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3, 1998
34. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32A:2413, 1996
35. Lichtenstein A, Berenson J, Norman D, Chang M-P, Carlile A: Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 74:1266, 1989
36. Nakamura M, Merchav S, Carter A, Ernst TJ, Demetri GD, Furukawa Y, Anderson K, Freedman AS, Griffin JD: Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells. J Immunol 143:3543, 1989
37. Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdorp PM, Di Guglielmo R: Production of interleukin-1 by bone marrow myeloma cells. Blood 74:380, 1989
38. Klein B: Cytokine, cytokine receptors, transduction signals and oncogenes in human multiple myeloma. Semin Hematol 32:4, 1995
39. Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824, 1992
40. Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69:508, 1993
41. Yaccoby S, Barlogie B, Epstein J: Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations. Blood 92:2908, 1998
42. Van Wart HE, Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase gene family. Proc Natl Acad Sci USA 85:5578, 1990
43. Vassalli J-D, Pepper MS: Membrane proteases in focus. Nature 370:14, 1994
44. Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC: Characterization of adhesion molecules on human myeloma cell lines. Blood 80:2306, 1992
45. Beutler E, Lichtman MA, Coller BS, Kipps TJ: Hematology (Williams) (ed 5). New York, NY, McGraw-Hill, 1995
46. Folkman J: New perspectives in clinical oncology from angiogenic research. Eur J Cancer 32A:2534, 1996